People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Pharmaceuticals, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. | — | Pharmaceuticals | Series D+ | $113.8M | $774.2M | 2022 |
| Innocoll Holdings, Inc. | — | Pharmaceuticals | Series A | $31.3M | $45.4M | 2009 |
| Petitioners Inc | — | Other Technology | Seed | $1.4M | $46.2M | 2014 |
| Grow Capital, Inc. | — | Other Technology | Pre-Seed | $1.3M | $8.5M | 2014 |
| Hancock Regional Surgery Center, LLC | — | Other Health Care | Pre-Seed | $791K | $7.0M | 2021 |
Michael Myers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Myers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gordon Dunn | 2 | 2 |
| Thomas Jones | 1 | 10 |
| Dennis Langer | 1 | 9 |
| MICHAEL HOGAN | 1 | 8 |
| JON MILLER | 1 | 8 |
| Kyle Fisher | 1 | 3 |
| Anthony Wild | 1 | 3 |
| Denise Carter | 1 | 2 |
| Steven A. Shallcross | 1 | 2 |
| James J. Olson | 1 | 2 |
| James Culverwell | 1 | 2 |
| Greg Costello | 1 | 2 |
| Natalie Leong | 1 | 2 |
| Kirk Blosch | 1 | 1 |
| Kevin Asher | 1 | 1 |
| Charles House | 1 | 1 |
| Greg Holmes | 1 | 1 |
| Gregory W. Holmes | 1 | 1 |
| Kirk W. Blosch | 1 | 1 |
| Christian J. Hoffmann, III | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.